Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)

OBJECTIVE: To evaluate the efficacy and safety of eptinezumab, a humanized anti-calcitonin gene-related peptide monoclonal antibody, in the preventive treatment of episodic migraine. METHODS: The PRevention Of Migraine via Intravenous ALD403 Safety and Efficacy-1 (PROMISE-1) study was a phase 3, mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashina, Messoud, Saper, Joel, Cady, Roger, Schaeffler, Barbara A, Biondi, David M, Hirman, Joe, Pederson, Susan, Allan, Brent, Smith, Jeff
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066477/
https://www.ncbi.nlm.nih.gov/pubmed/32075406
http://dx.doi.org/10.1177/0333102420905132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066477/
https://www.ncbi.nlm.nih.gov/pubmed/32075406
http://dx.doi.org/10.1177/0333102420905132

Ejemplares similares